Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Rosen who wrote (6409)	4/13/1999 1:03:00 AM
From: BDR	Respond to of 7041

<<I believe Scherings real intent in Mexico was to accumulate information to help them with their marketing of Vasomax in the U.S and western Europe...It is my understanding that data is often gathered long after some drugs are approved by following patients who are taking it.>> That would be useful information but how were they going to go about getting it? Were they giving the drug away? It sounds like there wasn't much product delivered to anybody so the numbers of participants must be small. The scenario you present may be reasonable but, in the absence of any evidence to support it, it is just as much speculation as anything offered by the shorts.